Evonik aligns two business lines with new growth strategy

Businesses outside core areas are to be sold or discontinued

16-Oct-2024 - Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. The remaining businesses outside these cores are to be sold to new owners or incorporated ...

Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...

Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

Programmable DNA hydrogels for advanced cell culture and personalized medicine

21-Aug-2023 - The team of Dr. Elisha Krieg at the Leibniz Institute of Polymer Research Dresden has developed a dynamic DNA-crosslinked matrix (DyNAtrix) by combining classical synthetic polymers with programmable DNA crosslinkers. DNA’s highly specific and predictable binding gives researchers unparalleled ...

IUTA and Green Elephant win second LABVOLUTION AWARD

11-May-2023 - Making everyday laboratory processes run more smoothly, increasing sustainability, improving efficiency and reducing costs – this is what the second LABVOLUTION AWARD was all about. The award ceremony took place on 10 May, during the second day. Alongside the Institut für Umwelt & Energie, ...

BMH invests in developer of sustainable cell cultivation systems

Green Elephant Biotech closes pre-seed funding round

15-Feb-2022 - Beteiligungs-Managementgesellschaft Hessen mbH ("BMH"), the medium-sized investment and venture capital company of the State of Hesse, is investing in Green Elephant Biotech GmbH. In addition to the lead investor BMH, a consortium of industry-experienced business angels also participated in the ...

First synthetic tissue model developed in which blood vessels can grow

02-Aug-2021 - A research team headed by biomedical engineer Dr Britta Trappmann from the Max Planck Institute for Molecular Biomedicine in Münster, Germany, has developed a cell culture system in which, for the first time, a functional blood vessel system is able to grow within a framework made of synthetic ...

Sartorius acquires majority stake in CellGenix

Portfolio expanded by cell culture components, such as growth factors, cytokines, and media

05-Jul-2021 - The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the biotechnology hub in Boston, Massachusetts USA, produces and ...

Cytiva acquires Intermountain Life Sciences

Double capacity for buffers and liquid cell culture media

02-Jul-2021 - Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase ...